FDA to Begin Reviewing Vyxeos as Treatment for Acute Myeloid Leukemia
News
The U.S. Food and Drug Administration has accepted Jazz Pharmaceuticals’ New Drug Application (NDA) for Vyxeos, an injected formulation of cytarabine and daunorubicin as a treatment for acute myeloid leukemia, ... Read more